April SAS-B figures: pastilles hit nearly one-third of approvals by Adam Sheldon May 7, 2026May 7, 2026 Approvals through the Special Access Scheme fell below 20,000 in April, as pastilles continued to cement […]
Survey of 239 patients suggests CBG may benefit pain, sleep and anxiety by Adam Sheldon March 9, 2026March 10, 2026
New research heralded a ‘game changer’ in shaping treatment plans for medicinal cannabis by Steve Jones September 24, 2025September 25, 2025
Young adults in the US are using cannabis to manage chronic pain by Martin Lane October 29, 2021April 29, 2024
International experts offer ‘weak’ support for cannabis pain trial by Martin Lane September 10, 2021April 26, 2024
Report finds sales of three major cannabis pharmaceutical products set to reach EU$1.8 billion by 2025 by Hannah Adler September 6, 2021April 26, 2024
